Oluwadunni E. Emiloju, MBBS, MS

One star
One star
One star
One star
One half star

Rating: 4.7 out of 5 (88 ratings)

Role

Medical Oncology
Specialty

Anal Cancer Appendix (Appendiceal) Cancer Colorectal Cancer Bile Duct (Biliary) Cancer Esophageal Cancer Gallbladder Cancer Gastrointestinal Stromal Tumor Liver Cancer Neuroendocrine Tumors Pancreatic Cancer Stomach (Gastric) Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2024

Call 404-778-1900

Background

A medical oncologist, Oluwadunni Emiloju, MBBS, MS, specializes in the treatment of gastrointestinal cancers. She joined the clinical staff at Winship Cancer Institute as an attending physician in 2024. Dr. Emiloju is an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.

Titles & Roles

Assistant Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Oncology/Hematology, 2024
Mayo Clinic College of Medicine and Science
Residency, Internal Medicine, 2021
Einstein Medical Center
Internship, Internal Medicine, 2020
Einstein Medical Center
Internship, 2010
University College Hospital, Ibadan, Nigeria
Medical Education, MD, 2009
University of Ibadan College of Medicine

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2024
Hematology
American Board of Internal Medicine, 2024
Internal Medicine
American Board of Internal Medicine, 2020

Professional Memberships

American Society of Clinical Oncology
American Society of Hematology
European Society for Medical Oncology

Research

Dr. Emiloju's research interests include:

Mechanisms and biomarkers of primary resistance to immune checkpoint inhibition in mismatch repair deficient metastatic colorectal cancer.
Premalignant lesions in early-onset colorectal cancer, and opportunities for interception.
Biomarker development for early detection of colorectal cancer using RNA sequencing.
Outcomes of early-onset colorectal cancer with synchronous oligometastases: improving patient selection for oligometastasectomy.
Improving response to immunotherapy in mismatch reapir proficient metastatic cancer through the use of cancer vaccines in combination with chemotherapy.
Exploiting combinatorial approaches targetting DNA damage repair pathways in advanced pancreatic adenocarcinoma and biliary tract cancers.
Preemptive pharmacogenomic testing for dihydropyridine dehydrogenase deficiency, correlation of abnormal DPYD genotype with clinical phenotype.

View Current Clinical Trials


Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial Phase II Conditions Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Winship Cancer Institute
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors Phase I/II Conditions Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, NSCLC, HNSCC, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer Location Winship Cancer Institute

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Phase
  
  II
- Conditions
  
  Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma
- Location
  
  Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Winship Cancer Institute

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase
  
  I/II
- Conditions
  
  Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, NSCLC, HNSCC, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer
- Location
  
  Winship Cancer Institute

Publications

Title/Journal	Authors	Publication Date
ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies. Annals of surgical oncology	O Emiloju, R Miao, O Alese	05/22/2025
The Evolving Role of Immunotherapy for Gastroesophageal Malignancies. Annals of surgical oncology	O Emiloju, R Miao, O Alese	05/07/2025

Title/Journal

Authors

Publication Date

ASO Author Reflections: The Evolving Role of Immunotherapy for Gastro-Esophageal Malignancies.

Annals of surgical oncology

O Emiloju, R Miao, O Alese

05/22/2025

The Evolving Role of Immunotherapy for Gastroesophageal Malignancies.

Annals of surgical oncology

O Emiloju, R Miao, O Alese

05/07/2025

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.7	One star One star One star One star One half star	Provider showed concern
4.7	One star One star One star One star One half star	Provider explained things clearly
4.6	One star One star One star One star One half star	Provider discussed treatment options
4.6	One star One star One star One star One half star	Provider included you in decisions
4.6	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	04/18/2025	Oluwadunni Emiloju, MDHematology and Oncology was awesome if lived in ATL; she would definitely be my doctor; concerned and gave encouragement.
One star One star One star One star One star	03/14/2025	The doctor was outstanding with the discussion of my surgeries. She even used a marker on the white board with her presentation. Great job!
One star One star One star One star One star	02/11/2025	Very good
One star One star One star One star One star	02/08/2025	I love Dr. Emilioju, she whole heartedly cares about her patients. She takes serious steps to get her patients well. She never gives up
One star One star One star One star One star	02/05/2025	This doctor, Dr. Dunni, is just an incredible doctor and person. So easy to speak to.
One star One star One star One star One star	01/07/2025	This was the first time meeting her face to face and she was wonderful. Answered all questions wonderful interaction with her.
One star One star One star One star One star	12/27/2024	Good experience
One star One star One star One star One star	12/20/2024	My doctor was outstanding in knowledge and presentation of such. She was patient and kind good people skills ,bedside manner was excellent. I was extremely impressed with her. Highly recommend her
One star One star One star One star One star	12/18/2024	Great winship always on time every time
One star One star One star One star One star	12/05/2024	Pleasant experience
One star One star One star One star One star	12/03/2024	She was great!
One star One star One star One star One star	11/10/2024	I love Dr. Emiloju.
One star One star One star One star One star	09/30/2024	"Dr Dunni" as she allows us to call her has the kindest bedside manner of any doctor I have met. I would highly recommend her and thank God every day I was referred to her.
One star One star One star One star One star	09/10/2024	She was very patient, very thorough. Easy to understand
One star One star One star One star One star	09/07/2024	Relocating to Georgia, and being assigned to Dr. Emiloju was a blessing - she is Heaven sent, she explains all my images and test and what we are going to do moving forward. I never leave her office confused.
One star Empty star Empty star Empty star Empty star	08/13/2024	I was very dissatisfied with the whole appointment